CTAG1B Antibody | ProSci 42-076 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

ProSci

product type :

antibody

product name :

CTAG1B Antibody

catalog :

42-076

quantity :

0.1 mg

price :

315 USD

clonality :

polyclonal

host :

goat

conjugate :

nonconjugated

reactivity :

human

application :

western blot, ELISA

product information

Catalog Number :

42-076

Product Name :

CTAG1B Antibody

Host Species :

Goat

Clonality :

Polyclonal

Conjugation :

Unconjugated

Product Type :

Primary Antibody

Size :

0.1 mg

List Price :

315 USD

CrossReactivity :

Human

ALTnames :

cancer antigen 3, New York esophageal squamous cell carcinoma 1, NY-ESO-1, LAGE2B, LAGE-2, ESO1, CTAG1, CTAG, cancer/testis antigen 1B, CTAG1B, LAGE2, LAGE2A AND Name: CTAG1B Synonyms: LAGE2B

Immunogen :

CTAG1B antibody was raised against a 13 amino acid synthetic peptide near the internal region of CTAG1B.

Purity :

CTAG1B antibody was purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Buffer :

CTAG1B antibody is supplied in Tris saline, 0.02% sodium azide, pH 7.3 with 0.5% bovine serum albumin.

Concentration :

500 ug/mL

Uses :

E, WB

Application Summary :

ELISA: Antibody detection limit dilution 1:16000. Western Blot: Approximately 28 kDa band in human testis lysates after 0.3 g/mL antibody staining.0 kDa according to NP_001318.1. The 28 kDa band was successfully blocked by incubation with the immunizing peptide.

Storage :

Aliquot and store at -20 C. Minimize freezing and thawing.

General References :

Adams S, O 1Neill DW, Nonaka D, Hardin E, Chiriboga L, Siu K, Cruz CM, Angiulli A, Angiulli F, Ritter E, Holman RM, Shapiro RL, Berman RS, Berner N, Shao Y, Manches O, Pan L, Venhaus RR, Hoffman EW, Jungbluth A, Gnjatic S, Old L, Pavlick AC, Bhardwaj N. Immunization of Malignant Melanoma Patients with Full-Length NY-ESO-1 Protein Using TLR7 Agonist Imiquimod as Vaccine Adjuvant. J Immunol. 2008 Jul 1;181(1):776-84.